Akzo Nobel India posts Q2 FY23 consolidated PAT at Rs. 65.4 Cr
The company has reported total income of Rs. 931 crores during the period ended September 30, 2022.
The company has reported total income of Rs. 931 crores during the period ended September 30, 2022.
The company has reported total income of Rs. 1211.06 crores during the period ended September 30, 2022.
The company has reported total income of Rs. 5595.74 crores during the period ended September 30, 2022.
The company is a leading specialty marine chemical manufacturer in India and focused on producing and exporting bromine, industrial salt, and sulphate of potash to customers around the world
The company has delivered a robust growth in revenue during the quarter, primarily led by high subsidy and MRP in the Nutrients business and volume led growth in others
The proposed capacity addition is 4,000 MTPA in a 10-12 months timeframe and will be a mix of debt and internal accruals
Performance and essential materials net pricing decreased 7% from the second quarter of 2022.
KBR is the world leader in ammonia technology, with around 50% share of licensed capacity.
The IFC Emerging Asia Fund, launched in 2016, makes equity and equity-like investments across all sectors in emerging markets in Asia alongside IFC.
UPL introduced a new range of insecticides in India for paddy and cotton crops.
Clariant completes acquisition of BASF’s U.S. Attapulgite business assets
Total revenue grows 23.7% Y-O-Y to Rs 542.90 crore
Inorganics Chemical division’s revenue grew by 98% to Rs. 1,130 crore in Q2 FY23 as compared to Rs. 572 crore in the Q2 FY22
Brownfield expansion to introduce a new speciality chemical to aid Barium portfolio diversification is on track and is expected to be commissioned by H1 FY24
This renewed contract will enable Aether to add to their topline by approximately Rs. 100 crore in FY23
Most of the new growth Capex investments are happening on the Specialty Chemicals and Nutrition side
With around 300 people already working at this site, the construction activity has started fully and hopefully the company will commercialize the first phase of the plant by December '23
Sumitomo India is on track to supply two (out of five planned) proprietary products to SCC Japan and its global affiliates in H2FY23 and Q1FY24, respectively.
Selling prices for synthetic resins, methyl methacrylate and various industrial chemicals improved due to an increase in raw material prices.
Quarterly adjusted EBITDA of $547.8 million
Subscribe To Our Newsletter & Stay Updated